Mark J. Holterman, Medical

Examining the Virtual Human Embryo Project

 

Virtual Human Embryo Project pic
Virtual Human Embryo Project
Image: ehd.org

As part of his work as a professor of surgery and pediatrics with the University of Illinois, Mark Holterman, MD, educates medical students and residents. Beyond this work, Dr. Mark Holterman serves on the Endowment for Human Development’s (EHD) scientific advisory board. The EHD hosts the Virtual Human Embryo (VHE) project, which is a compendium of the 23 Carnegie stages of embryo development that occur during the initial eight-week pregnancy period.

Featuring over 14,000 pages of diagrams, images, written content, and videos, the VHE took 11 years to develop. It was created via a collaboration between the Human Developmental Anatomy Center, which is part of the National Museum of Health and Medicine, and a team overseen by Dr. Raymond Gasser, one of the world’s leading embryologists.

The VHE project received $3.2 million in funding from organizations including the National Institute of Child Health and Human Development, resulting in the production of almost 34 gigabytes of imagery that acts as the most comprehensive gallery of embryonic development in the world.

The VHE is available to view at www.ehd.org/virtual-human-embryo/.

Advertisements
Mark J. Holterman, Medical

The Benefits of Membership to the AACT

 

Alliance for the Advancement of Cellular Therapies pic
Alliance for the Advancement of Cellular Therapies
Image: aact.co

A professor of surgery and pediatrics at the University of Illinois’ College of Medicine, Mark Holterman, MD, also draws on his extensive medical experience in his work with several external companies. In addition, Dr. Mark Holterman is a founding member of the Alliance for the Advancement of Cellular Therapies (AACT), which he also serves as a board member.

A nonprofit medical organization, the AACT aims to bring together the world’s leading physicians, scientists, researches, and device manufacturers to advance the fields of cell therapy and regenerative medicine. This collaboration is intended to enable the AACT to establish guidelines for clinical translation and best practices in regenerative medicine.

The benefits to AACT membership are numerous. In addition to enjoying discounted rates on a range of conferences and workshops, members receive a regular newsletter featuring the latest news in regenerative medicine and have the opportunity to meet and collaborate with other professionals in the field. Further, AACT members become part of a collective voice capable of expressing opinions directly to the US Food and Drug Administration and European Medicine Agency.